H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter“Fujirebio”) today announced that ...

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper ...

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Industry experts weigh in on current trends, challenges, and the future of the cell and gene therapy CDMO market. Cell and gene therapies, which fall under the general classification of advanced ...

The U.S. Small Molecule Innovator API CDMO Market offers growth opportunities fueled by rising demand for HPAPIs across ...

Indian pharma grapples headwinds of US pricing reform & Europe’s HTA-driven cost-effectiveness: Akash Kedia: Nandita Vijayasimha, Bengaluru Monday, June 9, 2025, 08:00 Hrs [IST] ...

BOSTON, June 9, 2025 /PRNewswire/ -- Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy (CGT), will showcase ...